Status:
TERMINATED
PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)
Lead Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Collaborating Sponsors:
Medtronic
Conditions:
Atrial Fibrillation
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Examination of CRT efficacy in patients with progressive heart failure and atrial fibrillation at the same time
Eligibility Criteria
Inclusion
- LVEF \<35%
- QRS time ≥150ms LBB
- NYHA classification ≥ NYHA III
- permanent (\> 6 months) Atrial Fibrillation
- sinus rhythm (control group)
- Condition after Implantation of a Medtronic CRT device
- written informed consent
Exclusion
- exchange of the current CRT device
- mitral incompetence (2. degree)
- no compliance
- participation in another study
- pregnancy
- patients with AV node
- patients after heart transplant or those who are on the transplant list
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00839566
Start Date
November 1 2008
End Date
July 1 2012
Last Update
July 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Professor Dr. med. Christian Perings
Lünen, Germany, 44534